Mithila Fadia

Mithila Fadia practices at Avance Care, PA in Raleigh, North Carolina.

Mithila Fadia's NPI, 1144631557, was assigned on May 20, 2014. Mithila Fadia holds North Carolina license 2021-03125.

Mithila Fadia's primary practice is Avance Care, PA, at 10208 Cerny St, Raleigh, NC 27617 in Wake County. The practice phone is (919) 655-1000.

Mithila Fadia's primary practice is Avance Care, PA in Raleigh, North Carolina. Mithila Fadia is also affiliated with WakeMed Raleigh Campus. The medical group on file is McCrimmon Primary Care Plus. Dmand AI also links Mithila Fadia to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mithila Fadia practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Mithila Fadia's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Mithila Fadia's licenses on file in 2 states: North Carolina and Illinois.

CMS data shows 414 Medicare services from Mithila Fadia across 5 procedure codes in 2024, for 216 Medicare patients. Medicare paid $44,448 for them. Every service was in an office.

CMS counts 216 Medicare patients who saw Mithila Fadia in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mithila Fadia's median patient age at 57, with 70% women.

In 2024, Mithila Fadia wrote 602 Medicare Part D claims for 165 patients. 85% of them were for generic drugs. CMS names the drug for 440 of them, across 17 drugs with 11 or more claims each, at $73,153 in total drug cost. In 2023, CMS named 103 claims across 3 drugs.

Mithila Fadia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mithila Fadia as offering telehealth.

CMS Open Payments shows 187 general payments to Mithila Fadia from 33 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $829.